Celadon Pharmaceuticals PLC (GB:CEL) has released an update.
Celadon Pharmaceuticals PLC, a UK-based pioneer in cannabis-based medicines, is set to expand its market presence by issuing 250,000 new Ordinary Shares at £0.01 each. This move comes as part of the company’s Long Term Incentive Plan, with shares expected to start trading on the AIM market around 21 May 2024. The company emphasizes that the newly issued shares will be equal to existing shares in terms of rights, and updates the total share count to 65,744,617 following the issue.
For further insights into GB:CEL stock, check out TipRanks’ Stock Analysis page.
